Literature DB >> 27008415

H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma.

Min Li1, Hanwen Chen1, Yuejiang Zhao1, Shuming Gao1, Cai Cheng1.   

Abstract

Osteosarcoma is the most common primary bone sarcoma around the world. The poor prognosis and high recurrence rate of osteosarcoma are largely due to the high rate of pulmonary metastasis. H19 has been reported to play a potential role in osteosarcoma progression. However, the exact molecular mechanism of metastasis involving H19 remains unclear. In the present study, we performed gain- and loss-of-function assays and found that H19 promotes migration and invasion in osteosarcoma cells. Furthermore, we showed that H19 promotes metastasis through upregulation of ZEB1 and ZEB2 by competitively binding the miR-200 family. Thus, our findings suggest important roles of H19 in osteosarcoma metastasis and indicate its potential application in osteosarcoma therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27008415     DOI: 10.1089/dna.2015.3171

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  20 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

Review 2.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

3.  A Survival Status Classification Model for Osteosarcoma Patients Based on E-CNN-SVM and Multisource Data Fusion.

Authors:  Qiang Zhang; Peng Peng; Yi Gu
Journal:  Comput Intell Neurosci       Date:  2022-07-09

4.  Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1.

Authors:  Chibo Liu; Jianjun Lin
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 5.  Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.

Authors:  Fang-teng Liu; Hua Pan; Guang-feng Xia; Cheng Qiu; Zheng-ming Zhu
Journal:  Oncotarget       Date:  2016-12-13

Review 6.  Regulation of Human Breast Cancer by the Long Non-Coding RNA H19.

Authors:  Jordan Collette; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

7.  Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells.

Authors:  Jing Li; YingYing Huang; XiaoJun Deng; ManLing Luo; XueFei Wang; HaiYan Hu; CiDi Liu; Mei Zhong
Journal:  Onco Targets Ther       Date:  2018-01-18       Impact factor: 4.147

8.  Long non-coding RNA ZFAS1 sponges miR-486 to promote osteosarcoma cells progression and metastasis in vitro and vivo.

Authors:  Nan Li; Zhen-Hui Sun; Min Fang; Jing-Yi Xin; Chun-You Wan
Journal:  Oncotarget       Date:  2017-10-24

9.  Long non-coding RNA TUG1 promotes migration and invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.

Authors:  Yong Wang; Tao Yang; Zhen Zhang; Ming Lu; Wei Zhao; Xiandong Zeng; Weiguo Zhang
Journal:  Cancer Sci       Date:  2017-05-19       Impact factor: 6.716

Review 10.  LncRNAs regulate cancer metastasis via binding to functional proteins.

Authors:  Liting Yang; Yanyan Tang; Fang Xiong; Yi He; Fang Wei; Shanshan Zhang; Can Guo; Bo Xiang; Ming Zhou; Ni Xie; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  Oncotarget       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.